One of the signaling cascades affected by NSAIDs is the NF-κB signalingthat targets inflammation, cancer, and growth; NSAIDs prevent NF-κB activation thus decreasing the translation and expression of genes that favor cell growth and supply genes necessary for its progression. The gene discussed is NFKB1; the disease is cancer.